Related Experiment Video
Updated: Sep 3, 2025
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Nonalcoholic Steatohepatitis in Children
1Professor of Pediatrics, Division of Gastroenterology Hepatology and Nutrition, Cincinnati Children's, Department of Pediatrics, Director, Nonalcoholic Steatohepatitis Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Insights
Nonalcoholic fatty liver disease (NAFLD) in children is a growing concern, influenced by genetics and environment. Current treatments are limited, highlighting the need for further research into effective therapies and long-term outcomes.
Area of Science:
- Pediatric gastroenterology and hepatology.
- Genetics and environmental influences on liver disease.
- Cardiovascular and metabolic disease risk factors.
Background:
- Nonalcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease in children.
- Both shared and unique genetic risk factors contribute to pediatric NAFLD, distinct from adult forms.
- Environmental factors significantly influence the early onset of NAFLD.
Purpose of the Study:
- To review the current understanding of pediatric nonalcoholic fatty liver disease.
- To highlight the genetic and environmental contributors to NAFLD in children.
- To discuss current treatment limitations and future research needs for pediatric NAFLD.
Main Methods:
- Literature review of pediatric NAFLD focusing on genetics, environment, and treatment.
- Analysis of current therapeutic strategies and their efficacy in children.
- Examination of associated comorbidities and long-term health risks.
Main Results:
- Pediatric NAFLD pathogenesis involves complex genetic and environmental interactions.
- Current treatment primarily focuses on lifestyle modifications, with limited success in persistent cases.
- Approved medications for NAFLD are lacking, though some anti-obesity and diabetes drugs show potential.
- Pediatric NAFLD is linked to increased risks of diabetes and cardiovascular issues.
Conclusions:
- Effective, targeted pharmacologic treatments for pediatric NAFLD are urgently needed.
- Long-term studies are essential to fully understand the adult consequences of childhood NAFLD.
- Addressing genetic and environmental factors is crucial for managing and preventing pediatric NAFLD progression.
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children. Although environmental factors are major contributors to early onset, children have both shared and unique genetic risk alleles as compared with adults with NAFLD. Treatment relies on reducing environmental risk factors, but many children have persistent diseases. No medications are approved specifically for the treatment of NAFLD, but some anti-obesity or diabetes treatments may be beneficial. Pediatric NAFLD increases the risk of diabetes and other cardiovascular risk factors. Long-term prospective studies are needed to determine the long-term risk of hepatic and non-hepatic morbidity and mortality in adulthood.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:20Inborn Errors of Metabolism